Koder, AhmetKilicaslan, SaffetBelada, AbdullahHabiloglu, Arif DoganAtaoglu, OzlemSungur, Mehmet AliAtik, Dursun2024-08-232024-08-2320231309-3878https://doi.org/10.18521/ktd.1217744https://search.trdizin.gov.tr/tr/yayin/detay/1203065https://hdl.handle.net/20.500.12684/13937Objective: Our study aims to evaluate the nasal mucociliary clearance (NMC) in Covid-19 patients who have been recently diagnosed and not been treated yet and investigate how Covid-19 affects NMC.Methods: A total of 120 participants, who applied to Duzce Ataturk State Hospital between September and November 2020, were included in our study. 60 of them were the participants, diagnosed with Covid-19. And 60 of them were the control group. The age range was 18 to 66. 60 participants, diagnosed with Covid-19 and not yet treated, were included in our study. Those with taste disorders were excluded from the study. The control group consisted of 60 healthy volunteers. NMC was evaluated using a saccharin test. The results were compared in the Statistical Package for Social Sciences (SPSS).Results: The study group, which consisted of 60 Covid-19 participants of whom treatment was not yet started, and the 60-participant healthy control group were evaluated in our study. The average age of the study group was 40,72 +/- 12,96 and 39,16 in the control group. The average NMC was 15,95 +/- 3,37 in the study group, and 8,38 +/- 1,03 in the control group. When evaluated statistically, it was found higher in the study group (p<0,001).Conclusions: NMC acts as a barrier for inhaled foreign bodies. It is a non-specific protection system against airborne pathogens. Consequently, NMC extends in Covid-19 patients.en10.18521/ktd.1217744info:eu-repo/semantics/openAccessCovid-19Nasal Mucociliary ClearanceSmell DisordersArticle1533083121203065WOS:001099802900005Q3